摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

11-amino-9-deoxo-3,11-dideoxy-9,11-N-nitriloethano-3-oxo-5-O-desosaminyl-6-O-methylerythronolide A 11,12-cyclic carbamate | 153954-82-6

中文名称
——
中文别名
——
英文名称
11-amino-9-deoxo-3,11-dideoxy-9,11-N-nitriloethano-3-oxo-5-O-desosaminyl-6-O-methylerythronolide A 11,12-cyclic carbamate
英文别名
TE-802;[3aS-(3aR*,4S*,7S*,9S*,10S*,11S*,13S*,15S*,15aS*)]-4-ethyl-3a,4,10,11,12,13,15,15a-octahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylohexopyranosyl]oxy]-14,1-(nitriloethano)-2H-oxacyclotetradecino [4,3-d]oxazole-2,6,8(7H,9H)-trione;(2R,4R,5R,6R,8R,11R,12S,19R,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-4-methoxy-2,4,6,8,12,19-hexamethyl-10,13-dioxa-15,18-diazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione
11-amino-9-deoxo-3,11-dideoxy-9,11-N-nitriloethano-3-oxo-5-O-desosaminyl-6-O-methylerythronolide A 11,12-cyclic carbamate化学式
CAS
153954-82-6
化学式
C33H55N3O9
mdl
——
分子量
637.814
InChiKey
JUXBXTDPLFNOCQ-NBQPNFJYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    775.0±60.0 °C(Predicted)
  • 密度:
    1.28±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    45
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    136
  • 氢给体数:
    1
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 2-halogenated derivatives of 5-0 desosaminyl-erythronolide A, their preparation process and their antibiotic use
    申请人:Aventis Pharma S.A.
    公开号:US06352983B1
    公开(公告)日:2002-03-05
    Novel compounds of the formula wherein the substituents are defined as in the application having antibiotic properties.
    该式中的新化合物具有抗生素性质,其中取代基的定义如申请中所述。
  • Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton
    作者:Sandra C. Mwakwari、William Guerrant、Vishal Patil、Shabana I. Khan、Babu L. Tekwani、Zachary A. Gurard-Levin、Milan Mrksich、Adegboyega K. Oyelere
    DOI:10.1021/jm100507q
    日期:2010.8.26
    Inhibition of histone deacetylase (HDAC) function is a validated therapeutic strategy for cancer treatment. Of the several structurally distinct small molecule histone deacetylase inhibitors (HDACi) reported, macrocyclic depsipeptides possess the most complex cap groups and have demonstrated excellent HDAC inhibition potency and isoform selectivity. Unfortunately, the development of macrocyclic depsipeptides has been hampered in part because of development problems characteristic of large peptides and the complex reaction schemes required for their synthesis. Herein we report that tricyclic ketolide TE-802 is an excellent mimetic for the peptide backbone of macrocyclic HDACi. Compounds derived from this template are particularly selective against HDACs 1 and 2 with nanomolar inhibitory activity. Interrogation of the association between a subset of these compounds and key HDAC isoforms, using AutoDock, enables a molecular description of the interaction between the HDAC enzyme's outer rim and the inhibitors' macrocyclic cap group that are responsible for compound affinity and presumably isoform selectivity.
  • Synthesis and Antibacterial Activity of the Tricyclic Ketolides TE-802 and Its Analogs.
    作者:MASATO KASHIMURA、TOSHIFUMI ASAKA、YOKO MISAWA、KEITA MATSUMOTO、SHIGEO MORIMOTO
    DOI:10.7164/antibiotics.54.664
    日期:——
    The novel 6-O-methyl tricyclic ketolides TE-802 and its analogs were synthesized by two successive cyclization reactions, 11, 12-cyclic carbamate formation by intramolecular Michael addition and 9, 11-diazaheptene ring construction by intramolecular dehydration reaction. These new tricyclic ketolides exhibited good in vitro antibacterial activity against not only erythromycin-susceptible strains but also erythromycin-resistant Staphylococcus aureus and Streptococcus pneumoniae, which are problematic pathogens of nosocomial and communityacquired respiratory tract infections, respectively.
    新型 6-O 甲基三环酮类化合物 TE-802 及其类似物是通过两个连续的环化反应合成的:分子内迈克尔加成反应生成 11,12-环氨基甲酸酯;分子内脱水反应生成 9,11-二氮杂庚烯环。这些新的三环酮烷类化合物不仅对红霉素敏感菌株,而且对耐红霉素的金黄色葡萄球菌和肺炎链球菌都具有良好的体外抗菌活性。
查看更多